NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell therapies for neurodegenerative diseases, has completed the dosing of all the participants in a phase 3 trial of NurOwn (MSC-NTF cells) in amyotrophic lateral sclerosis (ALS). The late-stage trial enrolled nearly 200 participants, who have been randomized […]
Covid-19 stem cell clinical trial : Celltex Therapeutics has been given the clearance by the US Food and Drug Administration (FDA) to move ahead with a phase 2 clinical trial for investigating the efficacy of autologous adipose tissue-derived mesenchymal stem cells (AdMSCs) in the prevention of Covid-19. In this connection, the Texas-based biotech company had […]
Citius Pharmaceuticals has made a Pre-IND submission to the US Food and Drug Administration for a novel stem cell therapy for acute respiratory distress syndrome (ARDS) in COVID-19 patients. In this regard, the late-stage specialty pharma company submitted a pre-IND meeting request and supporting briefing documents to the FDA’s Center for Biologics Evaluation and Research […]
Seneca Biopharma (formerly Neuralstem), a biopharma company engaged in developing treatments for diseases of high unmet medical need, has completed construction on its new cell manufacturing facility in Suzhou, China. The cell manufacturing facility will be used for manufacture NSI-566, the lead stem cell therapy of Seneca Biopharma for clinical trials in China, which includes […]
Aivita Biomedical, a stem cell company based in California, has rolled out a new product branded Provoque Eye Complex that can reduce skin aging signs that are visible in just about two weeks. Backed by a patent, the Provoque Eye Complex anti-aging skin care formula has been derived from stem cell. The aesthetic cosmetic formulation […]